• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

ASCRS 2023: ViaLase to present clinical data, technology overview

Article

The medical technology company ViaLase will reveal the 2-year data from their FLigHT clinical study as well as give additional information about their pipeline at ASCRS 2023.

Doctor from ViaLase presents data at ASCRS 2023 (Image credit: Adobe Stock/©wellphoto)

(Image credit: Adobe Stock/©wellphoto)

ViaLase announced that they will present clinical data from their first-in-human initial study of femtosecond laser image-guided high-precision trabeculotomy (FLigHT) as well as a technology overview at The American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, which will be held May 5-8, 2023 in San Diego, California. The clinical-stage medical tech company is developing a noninvasive image-guided femtosecond laser for the treatment of glaucoma in the hopes of addressing unmet needs in the conventional treatment paradigm.

“We are excited to present our 2-year clinical data to the ophthalmic community and continue to share the potential value of the micron accuracy, non-invasive treatment of glaucoma performed with advanced image-guided, femtosecond laser technology,” Tibor Juhasz, PhD, founder and CEO of ViaLase, said in a press release. “The results mark an important first step in demonstrating FLigHT’s potential as a safe and effective treatment option for patients with primary open angle glaucoma. We are optimistic about the new opportunities ViaLase’s FLigHT treatment can offer to practices and patients alike.”

Presenters for ViaLase include Cathleen M. McCabe, MD; Professor Zoltan Nagy, MD; and Richard A. Lewis, MD.

  • Up and coming glaucoma technologies: Almost ready for prime time
    • Presented by Cathleen M. McCabe, MD
    • Friday, May 5, 2023
    • 4:29-4:38 pm PDT
    • San Diego Convention Center, Upper Level, Room 6B
  • First-in-human study of femtosecond laser image-guided high-precision trabeculotomy (FLigHT) for glaucoma treatment: 2-Year outcomes
    • Presented by Professor Zoltan Nagy, MD
    • Saturday, May 6, 2023
    • 2:47-2:52 pm PDT
    • San Diego Convention Center, Upper Level, Room 5B
  • ASCRS innovator’s session – Angle imaging: The unmet need in MIGS
    • Presented by Richard A. Lewis, MD
    • Monday, May 8, 2023
    • 8:00-9:30 am PDT
    • San Diego Convention Center

Thomas W. Samuelson, MD, will also present a Marketplace Company Showcase as a part of Eyecelerator, a popular pipeline review and technology spotlight that often accompanies major meetings. Eyecelerator will take place on Thursday, May 4, 2023 from 1:00-2:30 pm PDT.

Related Videos
Jessica Steen, OD, FAAO, discusses systemic medication and ocular adverse effects at Vision Expo East 2024
The Vision Council CEO Ashley Mills gives a preview of the 2024 Vision Expo East event
Barry Eiden, OD, FAAO, FSLS, chats with Optometry Times about the 2024 IKA Symposium
Andy Morgenstern, OD, FAAO, FNAP chats with Optometry Times
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
© 2024 MJH Life Sciences

All rights reserved.